CellSeed's Regenerative medicine technology
-
-
CellSeed continue to focus our efforts on commercializing cell sheet regenerative medicine to bring these products to market.
Latest News
- IR Summary of Non-Consolidated Financial Results for the Six Months Ended June 30, 2023 (J-GAAP)
- IR Announcements Regarding Certain Media Coverages on MetaTech(AP) Inc. in Taiwan
- Others Company Brochure – Fiscal Year 2022, “With You CellSeed Vol.15”
- IR Summary of Non-Consolidated Financial Results for the Three Months Ended March 31, 2023 (J-GAAP)
- IR Summary of Non-Consolidated Financial Results for the Year Ended December 31, 2022 (J-GAAP)
